One lot of over-the-counter weight reduction drug Lipodrene w/25mg Ephedra Extract Dietary Supplement has been recalled for the presence of an unlawful ingredient that the FDA says could cause a number of critical issues.
“DMAA shouldn’t be a dietary ingredient, and DMAA-containing merchandise marketed as dietary dietary supplements are illegal and their marketing violates the law,” the FDA stated in an August 2018 web site submit linked off Wednesday’s Lipodrene recall discover.
That discover explains that the FDA’s drawback with DMAA (1,4-dimethylamylamine) is that “it may well slim blood vessels and arteries and trigger a corresponding rise in blood strain or different cardiovascular issues, akin to: shortness of breath, arrhythmias, elevated blood pressure, tightening in the chest, and heart attack.”
Lipodrene producer Hi-Tech Pharmaceuticals, which wrote the recall discover, says it’s investigating the issue.
This covers lot No. 001211197, expiration date 12/25. The lot quantity is on the underside of the bottle. Return the tablets to the retailer or to Hi-Tech for a full refund.
If this or any drug causes a medical drawback, notify a medical skilled, then let the Food and Drug Administration know through its MedWatch Adverse Event web page or by filling out a kind you may get by calling 800-332-1088. Only then do you have to think about calling the producer.
To ask questions on this recall, name Hi-Tech at 888-855-7919, 9 a.m. to five p.m., Eastern time, or e mail [email protected].
